Astrana Health (NASDAQ:ASTH) Shares Gap Up to $38.20

Astrana Health, Inc. (NASDAQ:ASTH)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $38.20, but opened at $40.16. Astrana Health shares last traded at $42.85, with a volume of 52,853 shares traded.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ASTH. Robert W. Baird began coverage on Astrana Health in a report on Thursday, May 30th. They set an “outperform” rating and a $54.00 price target on the stock. Baird R W raised Astrana Health to a “strong-buy” rating in a research report on Thursday, May 30th. Stifel Nicolaus upped their target price on Astrana Health from $45.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, June 27th. Finally, Truist Financial raised Astrana Health from a “hold” rating to a “buy” rating and upped their target price for the stock from $44.00 to $50.00 in a research report on Thursday. Four analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $50.50.

Astrana Health Trading Up 17.3 %

The company has a market capitalization of $2.51 billion, a price-to-earnings ratio of 33.07, a PEG ratio of 1.41 and a beta of 1.16. The stock’s 50-day simple moving average is $39.84. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.52 and a quick ratio of 1.52.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Tuesday, May 7th. The company reported $0.31 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). The company had revenue of $404.36 million during the quarter, compared to analysts’ expectations of $413.84 million. Astrana Health had a net margin of 4.29% and a return on equity of 10.22%. The company’s quarterly revenue was up 19.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.42 earnings per share. On average, sell-side analysts expect that Astrana Health, Inc. will post 1.41 EPS for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.